Caroline Voskens

1.9k total citations
31 papers, 1.0k citations indexed

About

Caroline Voskens is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Caroline Voskens has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Caroline Voskens's work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (8 papers). Caroline Voskens is often cited by papers focused on Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (8 papers). Caroline Voskens collaborates with scholars based in Germany, United States and United Kingdom. Caroline Voskens's co-authors include Markus F. Neurath, Sebastian Zundler, Gerold Schuler, Scott E. Strome, Raja Atreya, Imke Atreya, Anika Fischer, Timo Räth, Dan H. Schulze and Wei Lin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Caroline Voskens

30 papers receiving 1.0k citations

Peers

Countries citing papers authored by Caroline Voskens

Since Specialization

Citations

This map shows the geographic impact of Caroline Voskens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Voskens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Voskens more than expected).

Fields of papers citing papers by Caroline Voskens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Voskens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Voskens. The network helps show where Caroline Voskens may publish in the future.

Co-authorship network of co-authors of Caroline Voskens

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Voskens. A scholar is included among the top collaborators of Caroline Voskens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Voskens. Caroline Voskens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic traction force measurements of migrating immune cells in 3D biopolymer matrices 2024 ·Nature Physics ·(unknown), Mar Cóndor, (unknown), (unknown), (unknown), (unknown), (unknown), Caroline Voskens, Rocío López-Posadas, Kristian Franze, Silvia Budday, Christoph Mark, Ben Fabry, Richard Gerum	13
2	Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis 2023 ·Anticancer Research ·(unknown), Anne Petzold, Anja Wessely, (unknown), (unknown), Harald Knorr, Caroline Voskens, Markus V. Heppt, Carola Berking, Michael Erdmann	0
3	Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·Tanja M. Müller, Lijuan Liu, (unknown), Manuel Wiesinger, (unknown), (unknown), (unknown), Imke Atreya, Britta Siegmund, Raja Atreya, Ben Fabry, Carola Berking, Markus F. Neurath, Sebastian Zundler, Caroline Voskens	1
4	Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis 2022 ·Gut ·Caroline Voskens, (unknown), (unknown), Francesco Vitali, Sebastian Zundler, Marion Ganslmayer, (unknown), Manuel Wiesinger, (unknown), Mirko Kummer, Britta Siegmund, Elisabeth Schnoy, Timo Räth, Arndt Hartmann, Holger Hackstein, Beatrice Schuler‐Thurner, Carola Berking, Gerold Schuler, Raja Atreya, Markus F. Neurath	54
5	Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial 2021 ·BMJ Open ·Caroline Voskens, (unknown), (unknown), Francesco Vitali, Sebastian Zundler, (unknown), Manuel Wiesinger, (unknown), Britta Siegmund, Beatrice Schuler‐Thurner, Gerold Schuler, Carola Berking, Raja Atreya, Markus F. Neurath	13
6	Experiences of In-Patients with Skin Cancer in a German University Hospital Setting: A Cross-Sectional Survey 2021 ·Patient Preference and Adherence ·Theresa Steeb, Anja Wessely, (unknown), Caroline Voskens, Michael Erdmann, Lucie Heinzerling, Carola Berking, Markus V. Heppt	1
7	“I Feel I’m in Best Hands with You!”: A Survey of Patient Satisfaction in a German University Skin Cancer Centre 2021 ·Acta Dermato Venereologica ·Theresa Steeb, Anja Wessely, (unknown), Michael Constantin Kirchberger, Caroline Voskens, Michael Erdmann, (unknown), Carola Berking, Markus V. Heppt	1
8	Detecting long-range interactions between migrating cells 2021 ·Scientific Reports ·Claus Metzner, (unknown), Christoph Mark, (unknown), (unknown), Caroline Voskens, Ben Fabry	4
9	Intestinal Mucosal Wound Healing and Barrier Integrity in IBD–Crosstalk and Trafficking of Cellular Players 2021 ·Frontiers in Medicine ·(unknown), Maximilian Wiendl, Tanja M. Müller, (unknown), Caroline Voskens, Markus F. Neurath, Sebastian Zundler	80
10	Residual homing of α4β7-expressing β1 ⁺ PI16 ⁺ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab 2021 ·Gut ·Emily Becker, (unknown), Christine M. Gall, Maximilian Wiendl, Arif B. Ekici, (unknown), (unknown), Caroline Voskens, Ahmed N. Hegazy, Francesco Vitali, Raja Atreya, Tanja M. Müller, Imke Atreya, Markus F. Neurath, Sebastian Zundler	24
11	Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy 2021 ·Frontiers in Immunology ·Maximilian Wiendl, Emily M. Becker, Tanja M. Müller, Caroline Voskens, Markus F. Neurath, Sebastian Zundler	20
12	Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells 2020 ·Nature Communications ·Christoph Mark, (unknown), (unknown), Astrid Mainka, (unknown), (unknown), (unknown), (unknown), Sebastian Richter, Nina Bauer, Thomas E. Angelini, Gerold Schuler, Ben Fabry, Caroline Voskens	63
13	The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohnʼs Disease Effector T Cells In Vivo 2017 ·Inflammatory Bowel Diseases ·Sebastian Zundler, Anika Fischer, (unknown), (unknown), Raja Atreya, Timo Räth, Rocío López-Posadas, Caroline Voskens, Alastair J.M. Watson, Imke Atreya, Clemens Neufert, Markus F. Neurath	81
14	Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis 2017 ·Inflammatory Bowel Diseases ·Caroline Voskens, Anika Fischer, (unknown), Carmen Lorenz, Simon Hirschmann, Raja Atreya, Clemens Neufert, Imke Atreya, Markus F. Neurath, Gerold Schuler	26
15	Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders 2017 ·Frontiers in Immunology ·Manuel Wiesinger, (unknown), (unknown), Carmen Lorenz, Anika Fischer, Raja Atreya, Clemens Neufert, Imke Atreya, Alexander Scheffold, Beatrice Schuler‐Thurner, Markus F. Neurath, Gerold Schuler, Caroline Voskens	22
16	Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo 2015 ·Gut ·Anika Fischer, Sebastian Zundler, Raja Atreya, Timo Räth, Caroline Voskens, Simon Hirschmann, Rocío López-Posadas, Alastair J.M. Watson, Christoph Becker, Gerold Schuler, Clemens Neufert, Imke Atreya, Markus F. Neurath	120
17	Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells 2013 ·Atherosclerosis ·Barbara Dietel, Iwona Cicha, Caroline Voskens, Eric L.G. Verhoeven, Stephan Achenbach, Christoph D. Garlichs	87
18	Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity 2010 ·Journal of Experimental & Clinical Cancer Research ·Caroline Voskens, (unknown), Sandra Rollins, Dario Campana, (unknown), Dean L. Mann	51
19	CD137 Promotes Proliferation and Survival of Human B Cells 2009 ·The Journal of Immunology ·Xiaoyu Zhang, Caroline Voskens, Michelle A. Sallin, (unknown), Carolina L. Montes, Yue Zhang, Wei Lin, Guoyan Li, Erin Burch, Ming Tan, Ronna Hertzano, Andrei I. Chapoval, Koji Tamada, Brian Gastman, Dan H. Schulze, Scott E. Strome	54
20	FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck 2008 ·Cancer Immunology Immunotherapy ·Rodney J. Taylor, (unknown), (unknown), Caroline Voskens, Jeffrey S. Wolf, Wei Lin, Andrei I. Chapoval, Dan H. Schulze, Guo‐Liang Tian, Scott E. Strome	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact